Praxis Precision Medicines, Inc. (PRAX)
295.51
+8.60
(+3.00%)
USD |
NASDAQ |
Oct 02, 16:00
295.87
+0.36
(+0.12%)
Pre-Market: 20:00
Praxis Precision Medicines Market Cap : 8.250B for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 8.250B |
| October 01, 2026 | 8.010B |
| September 30, 2026 | 8.130B |
| September 29, 2026 | 7.845B |
| September 28, 2026 | 7.974B |
| September 25, 2026 | 7.838B |
| September 24, 2026 | 7.867B |
| September 23, 2026 | 7.876B |
| September 22, 2026 | 8.393B |
| September 21, 2026 | 8.343B |
| September 18, 2026 | 8.346B |
| September 17, 2026 | 8.667B |
| September 16, 2026 | 8.626B |
| September 15, 2026 | 8.735B |
| September 14, 2026 | 9.228B |
| September 11, 2026 | 9.340B |
| September 10, 2026 | 9.452B |
| September 09, 2026 | 9.640B |
| September 08, 2026 | 9.840B |
| September 04, 2026 | 9.821B |
| September 03, 2026 | 9.915B |
| September 02, 2026 | 9.980B |
| September 01, 2026 | 9.867B |
| August 31, 2026 | 9.779B |
| August 28, 2026 | 9.624B |
| Date | Value |
|---|---|
| August 27, 2026 | 10.27B |
| August 26, 2026 | 10.53B |
| August 25, 2026 | 10.27B |
| August 24, 2026 | 10.27B |
| August 21, 2026 | 10.49B |
| August 20, 2026 | 10.18B |
| August 19, 2026 | 10.78B |
| August 18, 2026 | 10.32B |
| August 17, 2026 | 10.51B |
| August 14, 2026 | 10.24B |
| August 13, 2026 | 10.29B |
| August 12, 2026 | 10.79B |
| August 11, 2026 | 10.35B |
| August 10, 2026 | 10.24B |
| August 07, 2026 | 10.07B |
| August 06, 2026 | 10.33B |
| August 05, 2026 | 8.912B |
| August 04, 2026 | 8.656B |
| August 03, 2026 | 8.511B |
| July 31, 2026 | 8.576B |
| July 30, 2026 | 8.574B |
| July 29, 2026 | 8.108B |
| July 28, 2026 | 8.241B |
| July 27, 2026 | 8.798B |
| July 24, 2026 | 9.063B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Insmed, Inc. | 24.26B |
| Vertex Pharmaceuticals, Inc. | 127.87B |
| BridgeBio Pharma, Inc. | 13.13B |
| Mirum Pharmaceuticals, Inc. | 5.370B |
| ACADIA Pharmaceuticals, Inc. | 3.434B |
Market Cap Related Metrics
| PEG Ratio | -4.296 |
| Price to Book Value | 6.152 |
| Price | 295.51 |
| Earnings Yield | -4.38% |
| PEGY Ratio | -4.296 |